Proposed deal with Europe sparks debate in Canadian drug industry
Published: 2012-05-23 06:57:00
Updated: 2012-05-23 06:57:00
There is a heated debate over Canada's intellectual property (IP) regime, and Canada stands to pay $2.8 billion more every year in drug costs while it undermines its generic-drug manufacturing sector, according to Edmonton Journal, Canadian daily newspaper.
The paper said that what's at stake ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
